导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 50.87% | 52/1050 |
| 近一周 | 5.01% | 11/1104 |
| 近一月 | 6.74% | 7/1103 |
| 近一季 | -13.65% | 827/1092 |
| 近半年 | 24.23% | 127/1070 |
| 近一年 | 48.94% | 88/1018 |
| 近两年 | 165.15% | 89/926 |
| 近三年 | 98.80% | 101/834 |
| 成立以来 | 146.07% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
12.38% 27/1070 |
67.70% 154/1101 |
- - |
- - |
| 2025 | 35.35% 391/1065 |
0.44% 764/1014 |
2.18% 490/1038 |
33.85% 300/1050 |
-1.47% 530/1065 |
| 2024 | -0.78% 601/1011 |
-8.36% 709/960 |
-2.66% 478/983 |
9.17% 691/991 |
1.88% 242/1011 |
| 2023 | -14.19% 488/952 |
1.57% 534/880 |
2.79% 72/895 |
-15.81% 792/915 |
-2.38% 260/952 |
| 2022 | -20.83% 360/867 |
-20.51% 545/773 |
9.95% 271/806 |
-1.63% 27/845 |
-7.92% 735/867 |
| 2021 | 26.26% 99/740 |
0.90% 112/580 |
17.66% 193/659 |
-4.28% 323/704 |
11.11% 53/740 |
| 2020 | 36.38% 321/554 |
-11.99% 394/419 |
32.99% 89/466 |
9.90% 255/517 |
6.02% 419/554 |
| 2019 | 48.07% 163/410 |
26.33% 609/1149 |
-6.41% 808/1231 |
8.27% 144/390 |
15.66% 42/410 |
| 2018 | -32.41% 249/349 |
- - |
- - |
- - |
-11.35% 447/1080 |
| 2017 | 26.05% 58/285 |
- - |
- - |
- - |
- - |
| 2016 | 2.99% 22/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 国寿安保成长优选股票A VS. 东吴新产业精选股票A(580008) |